Pleo Lari
FDA Label NDC 60681-1301

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Lari (NDC 60681-1301). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, otc - purpose, ingredients, inactive ingredient, tamper evident, dosage, warning, principal display panel - 10 ml bottle carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Homeopathic Analgesic Medicine

0.34 fl oz
(10 mL)

Otc - Purpose

For temporary relief of primary chronic polyarthritis symptoms.

Ingredients

10 mL Laricifomes officinalis e mycelio 5X.

Inactive Ingredient

Purified Water

Tamper Evident

Use this product only if tamper-evident strip at base of bottle cap is intact.

Dosage

5–10 drops, once daily, before mealtime.

Warning

If symptoms persist more than a few days, contact a licensed practitioner. As with any other drugs, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.

Principal Display Panel - 10 Ml Bottle Carton

Pleo™ –Lari
DROPS 5X
Homeopathic
Analgesic
Medicine

Indications: For
temporary relief
of primary
chronic
polyarthritis
symptoms.

0.34 fl oz
(10 mL)

Principal Display Panel (10 mL Bottle Carton)

Principal Display Panel (10 mL Bottle Carton)

* Please review the disclaimer below.